(NYSE: TRLV) Trulieve Cannabis's forecast annual revenue growth rate of -13.48% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 13.82%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.64%.
Trulieve Cannabis's revenue in 2026 is $1,139,040,000.On average, 9 Wall Street analysts forecast TRLV's revenue for 2026 to be $197,764,565,154, with the lowest TRLV revenue forecast at $188,883,453,426, and the highest TRLV revenue forecast at $204,504,350,724. On average, 8 Wall Street analysts forecast TRLV's revenue for 2027 to be $183,921,045,593, with the lowest TRLV revenue forecast at $170,955,623,810, and the highest TRLV revenue forecast at $199,882,783,476.
In 2028, TRLV is forecast to generate $102,136,636,181 in revenue, with the lowest revenue forecast at $22,909,493,979 and the highest revenue forecast at $185,735,010,738.